Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Rintatolimod

EU orphan designation number: EU/3/15/1480   
Active ingredient: Rintatolimod
Indication: Treatment of Ebola virus disease
Sponsor: NV Hemispherx BioPharma Europe
Leopold De Vriesstraat 26, 2600 Berchem, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
5/05/2015 Orphan designation EMA/OD/310/14 (2015)2944 of 24/04/2015
22/12/2015 Corrigendum (2015)9752 of 18/12/2015